脂质环境诱导2型糖尿病个体免疫细胞的内质网应激、TXNIP表达与炎症
研究比较非糖尿病、1型糖尿病和2型糖尿病个体外周血单个核细胞中TXNIP、炎症标志物及内质网应激未折叠蛋白反应标志物的表达,并分析血浆脂质组。发现2型糖尿病个体免疫细胞炎症表型与内质网应激及TXNIP表达相关,内质网应激可被特定外源性和内源性脂质环境所关联。
要点
- 2型糖尿病个体PBMCs中TXNIP、炎症及UPR标志物表达较非糖尿病和1型糖尿病个体增加。
- TXNIP表达与血浆空腹血糖、三酰甘油浓度及特定UPR标志物显著相关。
- 2型糖尿病个体血浆饱和二氢神经酰胺和鞘磷脂浓度升高,PBMCs中相关合成酶表达增加。
核心结论
- 2型糖尿病个体循环免疫细胞呈现炎症表型,该表型可关联至内质网应激和TXNIP表达。
- 免疫细胞内质网应激可关联至2型糖尿病中特定的外源性和内源性脂质环境。
研究设计与样本
- 在13名非糖尿病个体、23名1型糖尿病个体和81名2型糖尿病个体的外周血单个核细胞(PBMCs)中,用qRT-PCR定量TXNIP、炎症标志物、内质网应激未折叠蛋白反应(UPR)标志物及鞘脂代谢酶的表达。
- 对13名非糖尿病个体、35名1型糖尿病个体和94名2型糖尿病个体的血浆进行脂质组学分析。
- 在人单核细胞衍生的巨噬细胞(HMDMs)和THP-1细胞中分析内质网应激或特定脂质对TXNIP及炎症标志物表达的影响。
主要发现
- 与未患糖尿病个体或1型糖尿病个体相比,2型糖尿病个体PBMCs中TXNIP、炎症标志物和UPR标志物的表达增加。
- TXNIP表达与血浆空腹血糖、血浆三酰甘油浓度及特定UPR标志物显著相关。
- 在THP-1细胞或培养的HMDMs中诱导内质网应激导致UPR标志物、TXNIP、NLRP3和IL-1β表达增加。
- 化学 chaperone 降低2型糖尿病个体PBMCs中UPR标志物和TXNIP的表达。
- 血浆脂质组学分析显示,与未患糖尿病个体和1型糖尿病个体相比,2型糖尿病个体饱和二氢神经酰胺和鞘磷脂浓度增加;2型糖尿病个体PBMCs中二氢神经酰胺去饱和酶1和鞘磷脂合酶1表达增加。
关键数值与推荐
- 2型糖尿病个体PBMCs中TXNIP、炎症及UPR标志物表达较非糖尿病个体或1型糖尿病个体增加。
- TXNIP表达与血浆空腹血糖、血浆三酰甘油浓度及特定UPR标志物显著相关。
- 2型糖尿病个体血浆饱和二氢神经酰胺和鞘磷脂浓度较非糖尿病个体和1型糖尿病个体增加。
- 2型糖尿病个体PBMCs中二氢神经酰胺去饱和酶1和鞘磷脂合酶1表达增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study, we aim to determine whether the expression of TXNIP is altered in the circulating immune cells of individuals with type 2 vs type 1 diabetes and whether this can be related to specific causes and consequences of inflammation. METHODS: The expression of TXNIP, inflammatory markers, markers of the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress and enzymes involved in sphingolipid metabolism was quantified by quantitative reverse transcription real-time PCR (qRT-PCR) in peripheral blood mononuclear cells (PBMCs) of 13 non-diabetic individuals, 23 individuals with type 1 diabetes and 81 with type 2 diabetes. A lipidomic analysis on the plasma of 13 non-diabetic individuals, 35 individuals with type 1 diabetes and 94 with type 2 diabetes was performed. The effects of ER stress or of specific lipids on TXNIP and inflammatory marker expression were analysed in human monocyte-derived macrophages (HMDMs) and THP-1 cells. RESULTS: The expression of TXNIP and inflammatory and UPR markers was increased in the PBMCs of individuals with type 2 diabetes when compared with non-diabetic individuals or individuals with type 1 diabetes. TXNIP expression was significantly correlated with plasma fasting glucose, plasma triacylglycerol concentrations and specific UPR markers. Induction of ER stress in THP-1 cells or cultured HMDMs led to increased expression of UPR markers, TXNIP, NLRP3 and IL-1β. Conversely, a chemical chaperone reduced the expression of UPR markers and TXNIP in PBMCs of individuals with type 2 diabetes. The lipidomic plasma analysis revealed an increased concentration of saturated dihydroceramide and sphingomyelin in individuals with type 2 diabetes when compared with non-diabetic individuals and individuals with type 1 diabetes. In addition, the expression of specific enzymes of sphingolipid metabolism, dihydroceramide desaturase 1 and sphingomyelin synthase 1, was increased in the PBMCs of individuals with type 2 diabetes. Palmitate or C2 ceramide induced ER stress in macrophages as well as increased expression of TXNIP, NLRP3 and IL-1β. CONCLUSIONS/INTERPRETATION: In individuals with type 2 diabetes, circulating immune cells display an inflammatory phenotype that can be linked to ER stress and TXNIP expression. Immune cell ER stress can in turn be linked to the specific exogenous and endogenous lipid environment found in type 2 diabetes.
引用
- Szpigel A, Hainault I, Carlier A, et al. Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes. Diabetologia. 2017. PMID: 28988346. doi:10.1007/s00125-017-4462-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。